Fluicell is growing
At Fluicell, we are currently intensifying our product sales activities and our regenerative medicine development program and are…
At Fluicell, we are currently intensifying our product sales activities and our regenerative medicine development program and are…
Today, August 18 2022, Fluicell publishes the interim report for the period April 1 to June 30, 2022….
As we head towards the summer holiday season, Victoire Viannay gives an update in the latest issue of…
In an article published today, All3DP names Fluicell as one of the ten most innovative 3D printing companies…
Get the first glimpse of all the news in the latest version of the BioPen and Biozone 6…
Capturing the complexity of living cells is a major challenge for biological research. Cell population heterogeneity in physical,…
Not long ago we had the privilege to receive a visit by students from the International School of…
Today, May 12 2022, Fluicell publishes the interim report for the period January 1 to March 31, 2022….
Fluicell’s CEO Victoire Viannay has given a presentation for the company’s annual general meeting, discussing the year that…